Fenglavit

Medicinal product

(Invented) name

Fenglavit

Active substance (s)

Benfotiaminas/Piridoksino hidrochloridas/Cianokobalaminas

Strength

40 mg/90 mg/0,25 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Nereceptinis

Narrow therapeutic index (NTI)

ATC code (s)

A11DB, Vitamin B1 in combination with vitamin B6 and/or vitamin B12

Marketing authorisation holder

G.L. Pharma GmbH, Austrija

Date of authorisation

2025-08-07

Date of renewal

Documents

Stage

Registruotas

Controlled?

Controlled substance type

Legal basis

10a

Procedure number

SI/H/0302/001/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Benfotiaminas	40 mg
Piridoksino hidrochloridas	90 mg
Cianokobalaminas	0,25 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To
118244	104353	1104353	lizdinė plokštelė	N20	Nereceptinis	LT/1/25/5826/001	Netiekiama	-	-	No	-	-
118245	104355	1104355	lizdinė plokštelė	N50	Nereceptinis	LT/1/25/5826/002	Netiekiama	-	-	No	-	-
118246	104356	1104356	lizdinė plokštelė	N100	Nereceptinis	LT/1/25/5826/003	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2025-08-07	Registruotas